Tumor-associated immune microenvironment (TIME)

The tumor-associated immune microenvironment (TIME) is a complex and dynamic ecosystem within a tumor that comprises various immune cells, stromal cells, extracellular matrix components, and signaling molecules (NIH, 1.2.2). It plays a pivotal role in cancer progression by either facilitating an anti-tumor immune response or, more commonly in advanced stages, creating an immunosuppressive milieu that allows for immune evasion (NIH, 1.3.1). Key cellular players include tumor-infiltrating lymphocytes (TILs), tumor-associated macrophages (TAMs), myeloid-derived suppressor cells (MDSCs), and regulatory T cells (Tregs), which interact through a network of cytokines and chemokines (Frontiers, 1.3.4). The TIME is a major focus of modern oncology, as its composition and functional state significantly influence the efficacy of immunotherapies (LGC Standards, 1.3.2). Drugs such as immune checkpoint inhibitors (e.g., PD-1 and CTLA-4 blockers) and myeloid-modulating agents aim to reprogram the TIME to restore the host's ability to eliminate malignant cells (Biomed Frontiers, 1.2.1). Understanding the spatial and molecular heterogeneity of the TIME is essential for identifying predictive biomarkers and developing combination therapies to overcome resistance (Atlas Antibodies, 1.2.3).

Other names

Tumor immune microenvironmentImmunosuppressive tumor microenvironmentCancer immune microenvironmentTME (immune component)

Reprogramming of the immunosuppressive milieu through immune checkpoint blockade, myeloid cell modulation, and cytokine regulation to restore anti-tumor immunity.